Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Louise Magat) · Louise.Magat@ucsf.edu · 415-502-1822
Study coordinator · cancertrials@ucsf.edu · 877-827-3222
Contact: Principal Investigator (Robert Bok, MD, PhD)

Study leads

Robert Bok, MD, PhD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · Santa Monica, United States

Study of ZGGS34 in Participants With Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Zhengzhou, China

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China · Beijing, China

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States · Pittsburgh, United States